International Centre for Genetic Engineering and Biotechnology (ICGEB)
Principal Investigator
Dr Anmol Chandele
Group Leader
|
International Centre for Genetic Engineering and Biotechnology (ICGEB)
About
This project aims to generate and analyse human monoclonal antibodies from single cell sorted memory B cells derived from COVID-19 recovered individuals in India for their neutralising activity on SARS-CoV-2.
Patents
NA
Achievements
NA
Outcome / Output
This work showed that nearly half of the COVID-19 recovered individuals developed neutralising antibodies and these individuals can be identified by simple to use SARS-CoV-2 RBD ELISA’s.
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.